<p><em>公司根据新的战略原则执行，以推动可持续和盈利的增长</em></p>
<p>以色列特拉维夫和美国圣路易斯 --（商业新闻）-- <strong>ICL ( <em>NYSE: ICL) (TASE: ICL</em>)</strong> 今天宣布已达成最终协议，收购 Bartek Ingredients。Bartek 是食品级苹果酸和富马酸的全球领导者，服务于全球数百家客户和分销商，涵盖食品、饮料、糖果、烘焙及其他终端市场。这些功能性食品成分被食品和饮料公司用于增强风味、延长保质期和改善整体质量。这些添加剂还对个人护理产品的质量、安全性和有效性做出贡献。</p>
<p>Bartek 从其位于加拿大安大略省的总部向全球 40 多个国家分销其产品，并在北美运营唯一的垂直整合的马来酸酐和食品级苹果酸及富马酸生产设施。该业务目前每年产生约 6500 万美元的收入，并正在建设一座新的生产设施，预计将在 2026 年完成。新设施的完成预计将显著扩大产能和生产量，支持在全球功能性食品成分市场的参与，该市场预计到 2030 年销售额将超过 450 亿美元。</p>
<p>“我们很高兴通过收购 Bartek Ingredients 进一步扩展我们的专业食品解决方案组合——Bartek 是功能性食品成分的全球市场领导者。这项战略收购帮助我们为进一步增长做好准备，因为我们利用现有的全球食品业务拓展到其他食品成分领域，” ICL 的总裁兼首席执行官 Elad Aharonson 表示。“这项收购还推进了我们最近精炼的战略，专注于专业作物营养和专业食品解决方案这两个显著的增长引擎——这两个领域我们已经拥有深厚的经验和广泛的曝光。我们将继续在这些市场寻求额外的非有机增长机会，致力于为我们的股东创造长期价值和可持续增长。”</p>
<p>“ICL 作为食品和饮料行业成分和解决方案的领先全球制造商，与我们丰富的酸性物质经验非常契合，” Bartek Ingredients 的首席执行官 Andrew Ross 表示。“我们预计将最大化我们的潜力，并在不断增长的全球功能性食品成分市场中占据更大的份额，因为我们利用 ICL 的全球规模、技术专长——包括研发能力——以及数十年的经验，为客户提供额外的价值。”</p>
<p>此次收购需满足惯例的成交条件，包括监管批准，并将分两阶段完成。第一阶段预计在 2026 年第一季度完成，涉及约 9000 万美元的现金投资，以收购 Bartek 约 50% 的股份。第二阶段的投资时间和规模将取决于某些业务和整合里程碑，届时将收购 Bartek 剩余的股份。</p>
<p><strong>关于 ICL</strong></p>
<p>ICL 集团是一家领先的全球特种矿物公司，致力于为人类在食品、农业和工业市场的可持续发展挑战提供有影响力的解决方案。ICL 利用其独特的溴、钾和磷资源、全球专业人才以及专注于可持续发展的研发和技术创新能力，推动公司在各个终端市场的增长。ICL 的股票在纽约证券交易所和特拉维夫证券交易所双重上市（NYSE 和 TASE: ICL）。该公司在全球雇佣超过 12000 名员工，2024 年的收入约为 70 亿美元。</p>
<p>欲了解更多信息，请访问 ICL 的网站 icl-group.com。</p>
<p>要访问 ICL 的互动企业社会责任报告，请访问 icl-group-sustainability.com。</p>
<p>您还可以在 Facebook、LinkedIn、YouTube、X 和 Instagram 上了解更多关于 ICL 的信息。</p>
<p><strong>前瞻性声明</strong></p>
<p>本公告包含构成前瞻性声明的陈述，其中许多可以通过使用 “预期”、“相信”、“可能”、“期望”、“应该”、“计划”、“打算”、“估计” 和 “潜在” 等前瞻性词汇来识别。</p>
<p>前瞻性声明出现在本新闻稿的多个地方，包括但不限于关于公司的意图、信念或当前预期的陈述。前瞻性声明基于管理层的信念和假设以及当前可用的信息。这些声明面临风险和不确定性，实际结果可能与前瞻性声明中表达或暗示的结果有重大差异，原因包括但不限于：公司能否及时满足交易的成交条件；交易对 ICL 在食品成分市场定位的预期影响，ICL 在食品成分市场的战略重点；ICL 对满足交易成交条件所需时间的预期和假设，包括相关的监管批准；此外，没有保证新生产设施将按计划或及时完成，也没有保证它将显著增加产能和生产量；Bartek Ingredients 是否能够最大化其潜力或占据更大的市场份额。尽管 ICL 相信这些前瞻性声明所基于的预期和假设是合理的，但不应对前瞻性声明过度依赖，因为 ICL 无法保证这些声明将被证明是正确的。</p>
<p>交易完成的预期时间表可能会因多种原因而变化，包括未能在假定的时间内获得必要的监管批准，或需要额外时间来满足交易完成的条件。其他可能导致实际结果与前瞻性声明中所述的结果存在重大差异的因素包括但不限于对管理层在商业和财务前景、财务倍数和增值估计、未来趋势、计划、战略、定位、目标和预期等方面的预期的估计、预测和声明，未能按预期完成交易，以及成功将新业务有效整合到现有业务中的能力，整体经济、市场和商业条件，天气条件，政府和监管要求以及政府当局的行动，包括政府政策的变化、环境、税收和其他法律或法规的变化及其解释。因此，读者不应对本新闻稿中关于交易时间的前瞻性声明或 ICL 面临的其他更具体的风险和不确定性（如其于 2025 年 3 月 13 日提交的 20-F 表格年报中的 “风险因素” 部分所列）过度依赖，因为这些风险因素可能会不时在 ICL 向美国证券交易委员会提交的 6-K 表格当前报告及其他文件中更新。</p>
<p>前瞻性声明仅指其作出之日，公司不承担任何义务根据新信息或未来发展更新这些声明，或公开发布任何修订以反映后来的事件或情况，或反映意外事件的发生。</p>
<p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNTEyMTYxMzE4MzVyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNTEyMTYxMzE4MzVyMQ"/></p>
<p>在 businesswire.com 上查看源版本：https://www.businesswire.com/news/home/20251216131835/en/</p>
<p><strong>投资者和媒体联系人 - 全球</strong> Peggy Reilly Tharp</p>
<p>全球投资者关系副总裁</p>
<p>+1-314-983-7665</p>
<p>Peggy.ReillyTharp@icl-group.com</p>
<p><strong>投资者和媒体联系人 - 以色列</strong> Adi Bajayo</p>
<p>ICL 发言人</p>
<p>+972-3-6844459</p>
<p>Adi.Bajayo@icl-group.com</p>
<p>来源：ICL Group LTD</p>

<p>ICL 集团已达成一项最终协议，收购巴特克成分公司，该公司是食品级苹果酸和富马酸的全球领导者。此次收购将分两个阶段完成，第一阶段预计在 2026 年第一季度结束。这一战略举措旨在扩大 ICL 在特种食品解决方案方面的产品组合，并推动可持续增长</p>

<p><em>Company executing against new strategic principles, to drive sustainable and profitable growth</em></p>
<div class="lb-trans"><p><em>公司根据新的战略原则执行，以推动可持续和盈利的增长</em></p>
</div><p>TEL AVIV, Israel &amp; ST. LOUIS--(BUSINESS WIRE)-- <strong>ICL ( <em>NYSE: ICL) (TASE: ICL</em>)</strong> today announced it has entered into a definitive agreement to acquire Bartek Ingredients. Bartek is the global leader in food-grade malic and fumaric acid and serves hundreds of customers and distributors in the food, beverage, confectionery, bakery and other end-markets worldwide. These functional food ingredients are used by food and beverage companies to enhance flavor profiles, extend shelf life and improve overall quality. These additives also contribute to the quality, safety and efficacy of personal care products.</p>
<div class="lb-trans"><p>以色列特拉维夫和美国圣路易斯 --（商业新闻）-- <strong>ICL ( <em>NYSE: ICL) (TASE: ICL</em>)</strong> 今天宣布已达成最终协议，收购 Bartek Ingredients。Bartek 是食品级苹果酸和富马酸的全球领导者，服务于全球数百家客户和分销商，涵盖食品、饮料、糖果、烘焙及其他终端市场。这些功能性食品成分被食品和饮料公司用于增强风味、延长保质期和改善整体质量。这些添加剂还对个人护理产品的质量、安全性和有效性做出贡献。</p>
</div><p>Bartek distributes its products to more than 40 countries worldwide from its headquarters in Ontario, Canada, and operates the only vertically integrated maleic anhydride and food-grade malic and fumaric acid production facilities in North America. The business currently generates approximately $65 million in annual revenue and is in the process of constructing a new production facility, which is expected to be completed in 2026. Upon completion, the new facility is expected to significantly expand capacity and production volumes, supporting increased participation in the global functional food ingredients market, which is expected to exceed $45 billion in sales by 2030.</p>
<div class="lb-trans"><p>Bartek 从其位于加拿大安大略省的总部向全球 40 多个国家分销其产品，并在北美运营唯一的垂直整合的马来酸酐和食品级苹果酸及富马酸生产设施。该业务目前每年产生约 6500 万美元的收入，并正在建设一座新的生产设施，预计将在 2026 年完成。新设施的完成预计将显著扩大产能和生产量，支持在全球功能性食品成分市场的参与，该市场预计到 2030 年销售额将超过 450 亿美元。</p>
</div><p>“We are excited to expand our portfolio deeper into specialty food solutions, with the acquisition of Bartek Ingredients – a global market leader in functional food ingredients. This strategic acquisition helps position us for further growth, as we leverage our existing global food presence to expand into other food ingredient segments,” said Elad Aharonson, president and CEO of ICL. “This acquisition also advances our recently refined strategy, which focuses on the significant growth engines of specialty crop nutrition and specialty food solutions – two areas where we already have deep experience and broad exposure. We will continue to seek additional non-organic growth opportunities in these markets, driven by a commitment to creating long-term value and sustainable growth for our shareholders.”</p>
<div class="lb-trans"><p>“我们很高兴通过收购 Bartek Ingredients 进一步扩展我们的专业食品解决方案组合——Bartek 是功能性食品成分的全球市场领导者。这项战略收购帮助我们为进一步增长做好准备，因为我们利用现有的全球食品业务拓展到其他食品成分领域，” ICL 的总裁兼首席执行官 Elad Aharonson 表示。“这项收购还推进了我们最近精炼的战略，专注于专业作物营养和专业食品解决方案这两个显著的增长引擎——这两个领域我们已经拥有深厚的经验和广泛的曝光。我们将继续在这些市场寻求额外的非有机增长机会，致力于为我们的股东创造长期价值和可持续增长。”</p>
</div><p>“ICL’s position as a leading global manufacturer of ingredients and solutions for the food and beverage industry is very synergistic with our extensive acidulants experience,” said Andrew Ross, CEO of Bartek Ingredients. “We expect to maximize our potential and capture an even larger share of the growing global functional food ingredients market, as we leverage ICL’s global scale, technical expertise – including R&amp;D capabilities – and decades of experience, to provide additional value to customers.”</p>
<div class="lb-trans"><p>“ICL 作为食品和饮料行业成分和解决方案的领先全球制造商，与我们丰富的酸性物质经验非常契合，” Bartek Ingredients 的首席执行官 Andrew Ross 表示。“我们预计将最大化我们的潜力，并在不断增长的全球功能性食品成分市场中占据更大的份额，因为我们利用 ICL 的全球规模、技术专长——包括研发能力——以及数十年的经验，为客户提供额外的价值。”</p>
</div><p>The acquisition is subject to customary closing conditions, including regulatory approvals, and will be completed in two phases. The first phase, expected to close during the first quarter of 2026, involves a cash investment of approximately $90 million for the acquisition of approximately 50% of Bartek. The timing and scale of the investment in the second phase, which will result in the acquisition of the remaining shares of Bartek, are subject to certain business and integration milestones.</p>
<div class="lb-trans"><p>此次收购需满足惯例的成交条件，包括监管批准，并将分两阶段完成。第一阶段预计在 2026 年第一季度完成，涉及约 9000 万美元的现金投资，以收购 Bartek 约 50% 的股份。第二阶段的投资时间和规模将取决于某些业务和整合里程碑，届时将收购 Bartek 剩余的股份。</p>
</div><p><strong>About ICL</strong></p>
<div class="lb-trans"><p><strong>关于 ICL</strong></p>
</div><p>ICL Group is a leading global specialty minerals company, which creates impactful solutions for humanity's sustainability challenges in the food, agriculture and industrial markets. ICL leverages its unique bromine, potash and phosphate resources, its global professional workforce, and its sustainability focused R&amp;D and technological innovation capabilities, to drive the company's growth across its end markets. ICL shares are dual listed on the New York Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL). The company employs more than 12,000 people worldwide, and its 2024 revenues totaled approximately $7 billion.</p>
<div class="lb-trans"><p>ICL 集团是一家领先的全球特种矿物公司，致力于为人类在食品、农业和工业市场的可持续发展挑战提供有影响力的解决方案。ICL 利用其独特的溴、钾和磷资源、全球专业人才以及专注于可持续发展的研发和技术创新能力，推动公司在各个终端市场的增长。ICL 的股票在纽约证券交易所和特拉维夫证券交易所双重上市（NYSE 和 TASE: ICL）。该公司在全球雇佣超过 12000 名员工，2024 年的收入约为 70 亿美元。</p>
</div><p>For more information, visit ICL's website at icl-group.com.</p>
<div class="lb-trans"><p>欲了解更多信息，请访问 ICL 的网站 icl-group.com。</p>
</div><p>To access ICL's interactive CSR report, visit icl-group-sustainability.com.</p>
<div class="lb-trans"><p>要访问 ICL 的互动企业社会责任报告，请访问 icl-group-sustainability.com。</p>
</div><p>You can also learn more about ICL on Facebook, LinkedIn, YouTube, X and Instagram.</p>
<div class="lb-trans"><p>您还可以在 Facebook、LinkedIn、YouTube、X 和 Instagram 上了解更多关于 ICL 的信息。</p>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>This announcement contains statements that constitute forward-looking statements, many of which can be identified by the use of forward-looking words such as “anticipate,” “believe,” “could,” “expect,” “should,” “plan,” “intend,” “estimate” and “potential,” among others.</p>
<div class="lb-trans"><p>本公告包含构成前瞻性声明的陈述，其中许多可以通过使用 “预期”、“相信”、“可能”、“期望”、“应该”、“计划”、“打算”、“估计” 和 “潜在” 等前瞻性词汇来识别。</p>
</div><p>Forward-looking statements appear in a number of places in this press release and include, but are not limited to, statements regarding the Company’s intent, belief or current expectations. Forward-looking statements are based on management’s beliefs and assumptions and on information currently available to management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to: the Company’s ability to satisfy the closing conditions for the transaction on a timely basis or at all; the anticipated effect of the transaction on the positioning of ICL in the food ingredients market, ICL's strategic focus in on the food ingredients market; ICL's expectations and assumptions concerning the time necessary to satisfy the conditions to the closing of the transaction, including the regulatory approvals in connection therewith; in addition, there is no assurance that the new production facility will be completed as planned or in time, nor that it will significantly increase the capacity and production volumes as expected; that Bartek Ingredients will maximize its potential or capture a larger market share. Although ICL believes the expectations and assumptions on which such forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because ICL can give no assurance they will prove to be correct.</p>
<div class="lb-trans"><p>前瞻性声明出现在本新闻稿的多个地方，包括但不限于关于公司的意图、信念或当前预期的陈述。前瞻性声明基于管理层的信念和假设以及当前可用的信息。这些声明面临风险和不确定性，实际结果可能与前瞻性声明中表达或暗示的结果有重大差异，原因包括但不限于：公司能否及时满足交易的成交条件；交易对 ICL 在食品成分市场定位的预期影响，ICL 在食品成分市场的战略重点；ICL 对满足交易成交条件所需时间的预期和假设，包括相关的监管批准；此外，没有保证新生产设施将按计划或及时完成，也没有保证它将显著增加产能和生产量；Bartek Ingredients 是否能够最大化其潜力或占据更大的市场份额。尽管 ICL 相信这些前瞻性声明所基于的预期和假设是合理的，但不应对前瞻性声明过度依赖，因为 ICL 无法保证这些声明将被证明是正确的。</p>
</div><p>The anticipated timeline for completion of the transaction may change for a number of reasons, including the inability to secure necessary regulatory approvals in the time assumed or the need for additional time to satisfy the conditions to the completion of the transaction. Other factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, estimates, forecasts and statements as to management's expectations with respect to, among other things, business and financial prospects, financial multiples and accretion estimates, future trends, plans, strategies, positioning, objectives and expectations, failure to complete the transaction as contemplated and the ability to successfully integrate the new business into the existing business in an effective manner, general economic, market and business conditions, weather conditions, governmental and regulatory requirements and actions by governmental authorities, including changes in government policy, changes in environmental, tax and other laws or regulations and the interpretation thereof. As a result of the foregoing, readers should not place undue reliance on the forward‐looking statements contained in this press release concerning the timing of the transaction, or other more specific risks and uncertainties facing ICL, such as those set forth in the “Risk Factors” section of its Annual Report on Form 20-F filed on March 13, 2025 (reference no. 2025-02-016733), as such risk factors may be updated from time to time in its Current Reports on Form 6-K and other filings ICL makes with the U.S. Securities and Exchange Commission from time to time.</p>
<div class="lb-trans"><p>交易完成的预期时间表可能会因多种原因而变化，包括未能在假定的时间内获得必要的监管批准，或需要额外时间来满足交易完成的条件。其他可能导致实际结果与前瞻性声明中所述的结果存在重大差异的因素包括但不限于对管理层在商业和财务前景、财务倍数和增值估计、未来趋势、计划、战略、定位、目标和预期等方面的预期的估计、预测和声明，未能按预期完成交易，以及成功将新业务有效整合到现有业务中的能力，整体经济、市场和商业条件，天气条件，政府和监管要求以及政府当局的行动，包括政府政策的变化、环境、税收和其他法律或法规的变化及其解释。因此，读者不应对本新闻稿中关于交易时间的前瞻性声明或 ICL 面临的其他更具体的风险和不确定性（如其于 2025 年 3 月 13 日提交的 20-F 表格年报中的 “风险因素” 部分所列）过度依赖，因为这些风险因素可能会不时在 ICL 向美国证券交易委员会提交的 6-K 表格当前报告及其他文件中更新。</p>
</div><p>Forward-looking statements refer only to the date they are made, and the company does not undertake any obligation to update them in light of new information or future developments or to publicly release any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events.</p>
<div class="lb-trans"><p>前瞻性声明仅指其作出之日，公司不承担任何义务根据新信息或未来发展更新这些声明，或公开发布任何修订以反映后来的事件或情况，或反映意外事件的发生。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNTEyMTYxMzE4MzVyMQ" alt="" original-src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20251216131835r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en"/></p>
<p>View source version on businesswire.com: https://www.businesswire.com/news/home/20251216131835/en/</p>
<div class="lb-trans"><p>在 businesswire.com 上查看源版本：https://www.businesswire.com/news/home/20251216131835/en/</p>
</div><p><strong>Investor and Press Contact – Global</strong> Peggy Reilly Tharp</p>
<div class="lb-trans"><p><strong>投资者和媒体联系人 - 全球</strong> Peggy Reilly Tharp</p>
</div><p>VP, Global Investor Relations</p>
<div class="lb-trans"><p>全球投资者关系副总裁</p>
</div><p>+1-314-983-7665</p>
<div class="lb-trans"><p>+1-314-983-7665</p>
</div><p>Peggy.ReillyTharp@icl-group.com</p>
<div class="lb-trans"><p>Peggy.ReillyTharp@icl-group.com</p>
</div><p><strong>Investor and Press Contact - Israel</strong> Adi Bajayo</p>
<div class="lb-trans"><p><strong>投资者和媒体联系人 - 以色列</strong> Adi Bajayo</p>
</div><p>ICL Spokesperson</p>
<div class="lb-trans"><p>ICL 发言人</p>
</div><p>+972-3-6844459</p>
<div class="lb-trans"><p>+972-3-6844459</p>
</div><p>Adi.Bajayo@icl-group.com</p>
<div class="lb-trans"><p>Adi.Bajayo@icl-group.com</p>
</div><p>Source: ICL Group LTD</p>
<div class="lb-trans"><p>来源：ICL Group LTD</p>
</div>

ICL 集团通过收购 Bartek Ingredients 进一步扩展其全球食品配料业务 | ICL 股票新闻